India Inc Goes Abroad - MAPE Advisory Group

The Deal Details
Healthcare Sector
Acquirer Target Country Date Deal Size Remarks
Aurobindo Pharma Milpharm Ltd Europe Feb-06 Est. < 5.0 100% stake in UK based generic formulation pharmaceutical
company
Cadila Alpharma SAS France Jul-03 6.2 100% of the formulation business of Alpharma
Dishman
Pharmaceuticals
Dishman
Pharmaceuticals
Synprotec Ltd UK Apr-05 3.8 100% stake in UK based company having a track record of
more than 20 years of customer relationships with pharma
and chemical multinationals through its strong market
presence in Europe and the US
I03S Switzerland Dec-05 Est. < 5.0 100% stake in Switzerland based contract research company
Dr. Reddy's BMS Laboratories UK Mar-02 12.8 100% stake in UK based Company; annual turnover of
GBP8.0mn and profit after tax of GBP1.6mn in 2001
Dr. Reddy's Trigenesis Therapeutics
Inc
USA May-04 11.0 100% stake in a US based privately owned dermatology
Company
Dr. Reddy's API Business of Roche Mexico Nov-05 59.0 100% stake in API business at Mexico including all employees
and business supply contracts
Dr. Reddy's Betapharm
Arzneimittel GmbH
Glenmark Laboratorios Klinger Do
Bras
Glenmark Uni-Ciclo Harmonial
Brand
Germany Feb-06 570.3 100% stake in the fourth largest generic drug Co in Germany;
annual turnover of US$195.2mn; largest acquisition by an
Indian pharma firm.
Brazil Apr-04 5.2 100% stake in the Brazilian company with expected revenues
of US$7.0mn
Brazil Mar-05 4.6 100% buyout of a leading hormonal brand with sales of
US$3.1mn.
Glenmark Servycal SA Argentina Oct-05 Est. < 5.0 100% stake in the Argentine marketing company
Glenmark 2 FDA products from
Clonmel Healthcare
Ireland Dec-05 Est. < 5.0 100% stake in two FDA approved products from Clonmel
Healthcare Ltd; market-size for the products is
approximately US$50mn and has limited generic competition
22